Antibody Catalogue

Working With CRT

Testimonials

Licensing Opportunities

Small Molecules

Biological Therapeutics

CRT's Development Pipeline

Commercialisation Routes

Antibody Catalogue - C

Antigen	Clone
CEA (Carcinoembryonic Antigen)	NCRC16
Casein	F20.14
CD1c (Human Thymus Leukaemia antigen)	M241
CD2	X53(X/3)
CD3	PC3/188A
CD3	UCH-T1
CD45RA	BU77
CD4 V1 domain	QS4120
CD5 (Leu-1)	CD5/54/F6
CD5 (Leu-1)	Y2/178
CD5 (Leu-1)	H65
CD5 (Leu-1)	UCH-T2
CD8 (Leu-2)	14
CD8 (Leu-2)	C8/144B
CD8 (Leu-2)	UCH-T4
CD8 (Leu-2)	M236
CD8	BU88
CD9	BU16
CD9	P1/33/2
CD10 (CALLA)	SS2/36
CD11C	BU15
CD11b (integrin alpha M)	2LPM19c
CD11c (integrin alpha X)	KB90
CD13 (Aminopeptidase N)	22A5
CD14	UCH-M1
CD15	28
CD15	BU28
CD15	BU60
CD15	By87a
CD15	TG-1
CD15	29
CD16 (Fc gamma receptor III)	DJ130c
CD19	BU12
CD19	PDR134
CD20	PDR78
CD21 (complement receptor 2)	21A/5
CD21	BU32
CD21	BU33
CD21L (Dendritic reticulum cells)	R4/23
CD22 (BL-CAM)	4KB128
CD23	BU38
CD31 (PE-CAM-1)	JC70
CD32 (Fc gamma receptor II)	KB61
CD35 (Human complement receptor type 1; CR1)	E11
CD35 (Human complement receptor type 1; CR1)	To5
CD44	BU52
CD44 (Homing Cell Adhesion Molecule)	P2A1
CD45	BU64
CD45	2B11
CD45	C11
CD45	HLe-1 (2D1)
CD45 RO	UCH-L1
CD45R	351C5
CD45RA	4KB5
CD45RB	PD7/26
CD49d	BU49
CD50	BU65
CD50 (ICAM-3)	By44
CD50 (ICAM-3)	CG106
CD54	BU74
CD55 (Decay Accelerating Factor; DAF)	67
CD61	Y2/51
CD64	10.1
CD66 CE	By114
CD68	KP1
CD70	BU69
CD71	BU41
CD71 (Transferrin receptor)	Q1/71
CD72	BU40
CD74	BU43
CD74 (HLA-associated invariant chain)	By2
CDw75	ZB55
CD79a	HM57
CD79a	JCB117
CD79b	B29/123
CD85	VMP55
CD86	BU63
CD98	BU53
CD103 (integrin alpha E)	BP6
CD163 (haemoglobin scavenger receptor)	GHI/61
cdc2 (CDK1)	17 (A17)
cdc2 (CDK1)	Y100.4
cdc2 Xenopus	3E1.1
cdc6	cdc6 9H8/5
cdc13	6F11/2
cdc20	AR12
cdc20 (Xenopus laevis)	BA8
cdc27	AF 3.1
CDH-1	AR38
cdk1 (cdc2)	17 (A17)
cdk1 (cdc2)	Y100.4
cdk1 & cdk2	AN21.2
cdk2	AN4.3
CHD4	3F2/4
Chloramphenicol acetyl transferase (CAT)	CAT-1
Cig2	CIG2 3A11/5
Ciliated cells	LhS 28
C-Jun (phospho)	C-J 4C4/1
Clathrin heavy chain	STo 3H9
Collagen type VII	LH7.2
Common acute lymphocytic leukaemia antigen (CALLA; CD10)	SS2/36
Complement receptor 1 (CD35)	To5
Complement receptor 2 (CD21)	21A/5
Cul-1	AS97.1
Cyclin A	E23.1
Cyclin A	E43.2
Cyclin A	E67.1
Cyclin A	E70.1
Cyclin A	E72.1
Cyclin A1	XLA1-1
Cyclin A2	46B11
Cyclin B1	V143.1
Cyclin B1	V152
Cyclin B1	V63
Cyclin B1	V92.1
Cyclin B2	X121.10
Cyclin B2	X29.2
D-type cyclin encoded by Kaposi's Sarcoma Virus	94B
CYP 1A2	D15
CYP 2B1 & 2B2	b/e3
CYP 2B1 & 2B2	b/e4
CYP 2C2	h7
CYP 2C6	k1
CYP 3A	p6
CYP 4A	clo4
CYP 4A1	clo1

For further information about antibodies from CRT or to discuss sales or licensing options, please contact us at reagents@cancertechnology.com

Please note that CRT supplies to distributors only. However, we are happy to direct researchers to the appropriate commercial party to obtain antibodies within our portfolio. Click here to view disclaimer information.